SCHEMBL17265338

SCHEMBL17265338

CO[C@@H]1[C@@H](C)OC=C[C@H]1OCc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.40
MAPT P10636 1/20 0.40
CYP1A2 P05177 1/20 0.37
PSEN1 P49768 3/20 0.35
PSEN2 P49810 3/20 0.35
APH1B Q8WW43 3/20 0.35
NCSTN Q92542 3/20 0.35
APH1A Q96BI3 3/20 0.35
PSENEN Q9NZ42 3/20 0.35
PDPK1 O15530 1/20 0.35
MTOR P42345 1/20 0.35
TSHR P16473 4/20 0.34
SSTR1 P30872 1/20 0.34
SSTR2 P30874 1/20 0.34
SSTR4 P31391 1/20 0.34
SSTR3 P32745 1/20 0.34
SSTR5 P35346 1/20 0.34
CYP3A4 P08684 2/20 0.33
BCHE P06276 1/20 0.32
CCKBR P32239 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13869157 0.91 PDPK1 (0.40) CYP2C19MAPTCYP1A2PDPK1MTOR
SCHEMBL28345301 0.91 PDPK1 (0.40) CYP2C19MAPTCYP1A2PDPK1MTOR
SCHEMBL13869159 0.91 PDPK1 (0.40) CYP2C19MAPTCYP1A2PDPK1MTOR
SCHEMBL11380824 0.86 CYP2C19 (0.41) CYP2C19MAPTCYP1A2PSEN1PSEN2
SCHEMBL15366804 0.83 TSHR (0.43) CYP2C19MAPTPDPK1MTORTSHR
SCHEMBL15366807 0.83 TSHR (0.43) CYP2C19MAPTPDPK1MTORTSHR
SCHEMBL13869160 0.83 CYP2C19 (0.36) CYP2C19MAPTCYP1A2PDPK1MTOR
SCHEMBL17265241 0.83 CYP2C19 (0.36) CYP2C19MAPTCYP1A2PDPK1MTOR
SCHEMBL30761046 0.82 SSTR1 (0.41) CYP2C19MAPTCYP1A2PSEN1PSEN2
SCHEMBL13869144 0.82 SSTR1 (0.41) CYP2C19MAPTCYP1A2PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150329582-A1 SMALL MOLECULE COMPOUNDS SELECTIVE AGAINST GRAM-NEGATIVE BACTERIAL INFECTIONS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2015-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150329582-A1 SMALL MOLECULE COMPOUNDS SELECTIVE AGAINST GRAM-NEGATIVE BACTERIAL INFECTIONS MANBA, DDOST, PGLS CYP2C19 4244/4885MAPT 4591/4885CYP1A2 3821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.